These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 32868384)

  • 21. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma.
    Liang S; Wang Z; Chen J; Yang X; Liang X; Sun X; Li X; Zhou R; Li Y; Wang J
    J Surg Oncol; 2021 Sep; 124(3):411-419. PubMed ID: 34086291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green.
    Ianieri MM; Puppo A; Novelli A; Campolo F; Staniscia T; Di Martino G; Piovano E; Bruni F; Roviglione G; Mautone D; Ceccaroni M
    Gynecol Obstet Invest; 2019; 84(4):383-389. PubMed ID: 30661071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Conventional Radiotracer Tc-99(m) with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach.
    Buda A; Papadia A; Zapardiel I; Vizza E; Ghezzi F; De Ponti E; Lissoni AA; Imboden S; Diestro MD; Verri D; Gasparri ML; Bussi B; Di Martino G; de la Noval BD; Mueller M; Crivellaro C
    Ann Surg Oncol; 2016 Sep; 23(9):2959-65. PubMed ID: 27126631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
    Mendivil AA; Abaid LN; Brown JV; Mori KM; Beck TL; Epstein HD; Micha JP; Goldstein BH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():29-32. PubMed ID: 29529474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
    Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution.
    Tucker K; Staley SA; Gehrig PA; Soper JT; Boggess JF; Ivanova A; Rossi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):346-351. PubMed ID: 31911534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection.
    Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A
    Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of sentinel lymph node mapping for endometrial cancer.
    Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
    Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.
    How J; Gotlieb WH; Press JZ; Abitbol J; Pelmus M; Ferenczy A; Probst S; Gotlieb R; Brin S; Lau S
    Gynecol Oncol; 2015 Jun; 137(3):436-42. PubMed ID: 25870917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical re-injection of indocyanine green to improve sentinel lymph node detection in endometrial cancer.
    Maramai M; Achilarre MT; Aloisi A; Betella I; Bogliolo S; Garbi A; Maruccio M; Quatrale C; Aletti GD; Mariani A; Colombo N; Maggioni A; Multinu F; Zanagnolo V
    Gynecol Oncol; 2021 Jul; 162(1):38-42. PubMed ID: 33906784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of sentinel Lymph node mapping with different volumes of Indocyanine green in early-stage ENdometrial cancer: the ALIEN study.
    Mauro J; Raimondo D; Di Martino G; Gasparri ML; Restaino S; Neola D; Clivio L; Calidona C; Fruscio R; Vizzielli G; Uccella S; Papadia A; Seracchioli R; Buda A
    Int J Gynecol Cancer; 2024 Jun; 34(6):824-829. PubMed ID: 38336372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough?
    Papadia A; Imboden S; Gasparri ML; Siegenthaler F; Fink A; Mueller MD
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1831-6. PubMed ID: 27318493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
    Buda A; Di Martino G; Vecchione F; Bussi B; Dell'Anna T; Palazzi S; Cantù MG; Marchette MD; Milani R
    Int J Gynecol Cancer; 2015 Oct; 25(8):1513-8. PubMed ID: 26397069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.
    Wang Q; Wang B; Wang L; Xue Y; Shan W; Luo X; Wang C; Chen X
    J Surg Oncol; 2021 Dec; 124(8):1551-1560. PubMed ID: 34496048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - A proposed management algorithm.
    Zammarrelli WA; Afonso AM; Broach V; Sonoda Y; Zivanovic O; Mueller JJ; Leitao MM; Chan A; Abu-Rustum NR
    Gynecol Oncol; 2021 Aug; 162(2):262-267. PubMed ID: 33992449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic near-infrared fluorescent imaging as an alternative option for sentinel lymph node mapping in endometrial cancer: A prospective study.
    Taşkın S; Şükür YE; Altın D; Ersöz CC; Turgay B; Kankaya D; Güngör M; Ortaç F
    Int J Surg; 2017 Nov; 47():13-17. PubMed ID: 28919095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.